PE anti-human CD25 Antibody

Pricing & Availability
Clone
BC96 (See other available formats)
Regulatory Status
RUO
Workshop
V T-072
Other Names
Low affinity IL-2R, IL-2R α chain, Tac, p55
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
bc96
PHA-stimulated (3 day) human peripheral blood lymphocytes were stained with CD25 (clone BC96) PE (solid line) or mouse IgG1, κ PE isotype control (dotted line).
  • bc96
    PHA-stimulated (3 day) human peripheral blood lymphocytes were stained with CD25 (clone BC96) PE (solid line) or mouse IgG1, κ PE isotype control (dotted line).
See PE spectral data
Cat # Size Price Quantity Check Availability Save
302605 25 tests $39
Check Availability


Need larger quantities of this item?
Request Bulk Quote
302606 100 tests $94
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD25 is a 55 kD type I transmembrane glycoprotein also known as the low affinity IL-2 receptor α chain or Tac. It is expressed on progenitor lymphocytes, activated T and B cells, and activated monocytes/macrophages. CD25 is also expressed on a subset of non-stimulated CD4+ T cells termed T regulatory cells. CD25 associates with the IL-2 receptor β (CD122) and common γ chains (CD132) to form the high affinity IL-2R complex.

Product Details
Technical data sheet

Product Details

Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The CD25 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications include: immunocytochemistry3.

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  3. Ernst CW, et al. 2007. Clin. Exp. Immunol. 148:271. (ICC) PubMed
Product Citations
  1. Wang B, et al. 2017. Stem Cell Res Ther.. 10.1186/s13287-017-0744-6. PubMed
  2. Goletz C, et al. 2018. Front Immunol. 9:1614. PubMed
  3. Wang L, et al. 2018. Oncol Lett. 15:8635. PubMed
  4. de Boer B et al. 2018. Cancer cell. 34(4):674-689 . PubMed
  5. Meng S, et al. 2018. Mol Med Rep. 18:4247. PubMed
  6. Savage TM, et al. 2018. JCI Insight. 3:. PubMed
  7. Lopatina T, et al. 2018. Sci Rep. 8:17458. PubMed
  8. Li X, et al. 2019. Mol Med Rep. 19:4195. PubMed
  9. Tang M, et al. 2019. Biomed Res Int. 2019:1050285. PubMed
  10. Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
  11. Miragaia RJ, et al. 2019. Immunity. 50:493. PubMed
  12. Iwahori K, et al. 2019. Sci Rep. 2.205555556. PubMed
  13. Yang M, et al. 2019. Cell Physiol Biochem. 52:1178. PubMed
  14. Soodgupta D, et al. 2019. Cell Rep. 29:829. PubMed
  15. Miao L, et al. 2020. Theranostics. 0.7625. PubMed
  16. Ajith A, et al. 2019. FASEB J. 33:5220. PubMed
  17. Freeman ZT, et al. 2020. J Clin Invest. 130:1405. PubMed
  18. Saadati S, et al. 2020. Avicenna J Med Biotechnol. 0.591666667. PubMed
  19. Kim N, et al. 2020. Nat Commun. 2.045138889. PubMed
  20. Netsrithong R, et al. 2020. Stem Cell Research. 39:101487.. PubMed
  21. Ramien C, et al. 2020. Cell Reports. 29(4):810-815. PubMed
  22. Wang AS, et al. 2020. Molecular Cell. 79(2):221-233.e5.. PubMed
  23. Zhang W, et al. 2012. J Biol Chem. 287:34157. PubMed
  24. Chen Y, et al. 2012. PLoS One. 7:e47190. PubMed
  25. Ferraro A, et al. 2014. Proc Natl Acad Sci U S A. 111:1111. PubMed
  26. Reichwald K, et al. 2014. PLoS One. 9:105627. PubMed
  27. Han L, et al. 2014. J Biol Chem. 289:25546. PubMed
  28. Fujigaki J, et al. 2015. PLoS One. 10: 0132521. PubMed
  29. Luo X, et al. 2015. J Biol Chem. 290: 28675 - 28682. PubMed
  30. James E, et al. 2016. PLoS Pathog. 12: 1005375. PubMed
  31. Bal S, et al. 2016. Nat Immunol. 10.1038/ni.3444. PubMed
  32. Lima J, et al. 2016. Reprod Sci. 10.1177/1933719116653680. PubMed
  33. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  34. Zhou Y, et al. 2016. J Leukoc Biol. 100: 1201 - 1211. PubMed
  35. Cerny D, et al. 2016. J Allergy Clin Immunol. 138:1709-1712. PubMed
  36. Riner D, et al. 2016. PLoS Negl Trop Dis. 10:e0005180. PubMed
  37. Dyson MR, et al. 2020. MAbs. 12:1829335. PubMed
  38. Welch JL, et al. 2020. FEBS Lett. 594:695. PubMed
  39. Klemm F, et al. 2020. Cell. 181(7):1643-1660.e17. PubMed
  40. Vinogradova EV, et al. 2020. Cell. 182(4):1009-1026.e29. PubMed
  41. Zhang B, et al. 2020. Cell Chemical Biology. 28(1):60-69.e7. PubMed
  42. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  43. Loo Yau H, et al. 2021. STAR Protocols. 2(2):100549. PubMed
  44. Fierle JK, et al. 2021. Cell Reports Medicine. 2(8):100362. PubMed
  45. Kobayashi Y, et al. 2020. Int J Oncol. 999:56. PubMed
  46. Imura Y, et al. 2020. JCI Insight. :5. PubMed
  47. Robertson N, et al. 2020. J Biol Chem. . PubMed
  48. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  49. Wei H, et al. 2021. Malar J. 20:89. PubMed
  50. Xun X, et al. 2021. Am J Transl Res. 13:4360. PubMed
  51. Ajith A, et al. 2021. Front Immunol. 12:687715. PubMed
  52. Keefe RC, et al. 2021. Sci Rep. 11:14933. PubMed
  53. Cohen CA, et al. 2021. Nat Commun. 12:4678. PubMed
  54. Robertson N, et al. 2020. J Biol Chem. 295:18436. PubMed
  55. Choe JH, et al. 2021. Sci Transl Med. 13:. PubMed
  56. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  57. Tian M, et al. 2021. Elife. 10:. PubMed
  58. Chruewkamlow N, et al. 2021. Stem Cell Res Ther. 12:520. PubMed
  59. Wu D, et al. 2020. Biomark Res. 8:3. PubMed
  60. Mengrelis K, et al. 2021. Pediatr Transplant. 25:e13930. PubMed
  61. Chen Y, et al. 2021. Transl Lung Cancer Res. 10:2193. PubMed
  62. Houtsma R, et al. 2021. STAR Protoc. 2:100864. PubMed
  63. Erdem A, et al. 2022. Nat Commun. 13:1105. PubMed
  64. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  65. Shen X, et al. 2021. Front Immunol. 12:710750. PubMed
  66. Vinogradova EV, et al. 2021. STAR Protoc. 2:100458. PubMed
  67. You M, et al. 2021. Nat Cell Biol. 23:620. PubMed
  68. Högelin KA, et al. 2021. iScience. 24:103078. PubMed
  69. Lee JM, et al. 2022. Lupus Sci Med. 9:. PubMed
  70. Hui Z, et al. 2022. Cell Death Dis. 13:607. PubMed
  71. Csomós K, et al. 2022. Nat Immunol. 23:1256. PubMed
  72. Batikan O, et al. 2022. J Coll Physicians Surg Pak. 32:1004. PubMed
  73. Carnevale J, et al. 2022. Nature. 609:174. PubMed
  74. Meléndez AV, et al. 2022. Cell Mol Life Sci. 79:513. PubMed
  75. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  76. Pothlichet J, et al. 2022. Front Immunol. 13:824746. PubMed
  77. Bellini N, et al. 2022. iScience. 25:105234. PubMed
  78. Scarneo SA, et al. 2022. Sci Rep. 12:18091. PubMed
  79. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  80. Hong Y, et al. 2022. J Leukoc Biol. 112:425. PubMed
  81. Zhang H, et al. 2023. Nat Immunol. 24:96. PubMed
  82. Xu Q, et al. 2023. Nat Immunol. 24:186. PubMed
  83. Ando M, et al. 2021. Cancer Res Commun. 1:41. PubMed
  84. Hu Y, et al. 2023. Front Immunol. 14:1128423. PubMed
  85. Pfister F, et al. 2023. Methods Mol Biol. 2644:331. PubMed
RRID
AB_314275 (BioLegend Cat. No. 302605)
AB_314276 (BioLegend Cat. No. 302606)

Antigen Details

Structure
Type I transmembrane glycoprotein, 55 kD
Distribution

Activated T cells and B cells, monocytes/macrophages, Treg

Function
Associates with IL-2 receptor β (CD122) and γ chains (CD132) to form high affinity IL-2R complex
Ligand/Receptor
IL-2
Cell Type
B cells, Macrophages, Monocytes, T cells, Tregs
Biology Area
Cell Biology, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References

1. Taniguchi T, et al. 1993. Cell 73:5.
2. Waldmann T. 1991. J. Biol. Chem. 266:2681.

Gene ID
3559 View all products for this Gene ID
UniProt
View information about CD25 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 3    Revision Date: 12/15/2021

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account